Skip to main content
. 2020 Sep 4;12(9):2518. doi: 10.3390/cancers12092518

Figure 8.

Figure 8

Flow-chart model proposal to explain the NLRP1 involvement in melanoma chemoresistance. NLRP1 is a component of the activated and NF-κB-associated signaling pathways responsible for resistance following chemotherapeutic assaults.